Rethinking placebo-controlled clinical trials in psychedelic therapies for psychiatric illness
The British Journal of Psychiatry · 2025-10 · 227 (4) · 721-722
DOI: 10.1192/bjp.2025.51 ↗Kurz gefasst
Fachartikel in der Zeitschrift The British Journal of Psychiatry, online erschienen am 21.07.2025. Verfasst von Amy Lehrner und 2 weiteren Autor:innen. Beteiligte Einrichtung: James J Peters VA Medical Center, Bronx, NY, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- James J Peters VA Medical Center, Bronx, NY, USA.
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, NY, USA.
- The Parsons Research Center for Psychedelic Healing, Icahn School of Medicine at Mount Sinai, NY, USA.
ORCID-Profile: Amy Lehrner
Zitieren
APA
Lehrner, A., Hildebrandt, T. B., & Yehuda, R. (2025). Rethinking placebo-controlled clinical trials in psychedelic therapies for psychiatric illness. The British Journal of Psychiatry, 227(4), 721-722. https://doi.org/10.1192/bjp.2025.51
Vancouver
Lehrner A, Hildebrandt TB, Yehuda R. Rethinking placebo-controlled clinical trials in psychedelic therapies for psychiatric illness. The British Journal of Psychiatry. 2025;227(4):721-722. doi:10.1192/bjp.2025.51
BibTeX
@article{Lehrner2025,
author = {Lehrner, Amy and Hildebrandt, Thomas B and Yehuda, Rachel},
title = {Rethinking placebo-controlled clinical trials in psychedelic therapies for psychiatric illness},
journal = {The British Journal of Psychiatry},
year = {2025},
volume = {227},
number = {4},
pages = {721--722},
doi = {10.1192/bjp.2025.51}
}
EUVIMED